The Motley Fool
18 Jul 2026, 13:15 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
Pfizer's trailing 12-month dividend payout ratio exceeded 130% at the end of Q1 2026, with a cash dividend payout ratio of 103%. — A payout ratio over 100% indicates the company is paying out more in dividends than it is earning, significantly increasing the risk of a dividend cut.
-0.60Pfizer faces upcoming patent expirations for major drugs, including Ibrance (2027), Eliquis (2028), and Vyndaqel (2028), without immediate replacements. — Loss of patent protection leads to generic competition and sharp revenue declines, threatening long-term earnings stability.
-0.50Pfizer suffered a setback in its weight-loss pipeline after dropping a GLP-1 drug candidate in 2025. — Failure in the high-growth GLP-1 market limits Pfizer's ability to offset revenue losses from patent expirations.
-0.40Continue reading
6 related stories
Top 3 movers · tap to explore
Pfizer currently offers a high dividend yield of approximately 7%, significantly above the S&P 500 and pharmaceutical industry averages. — High yields attract income-focused investors, providing a price floor for the stock despite fundamental risks.
+0.30Pfizer ended Q1 with $1.7 billion in cash and $11.3 billion in short-term investments to support its dividend obligations. — Liquidity provides a short-term cushion that prevents an immediate dividend suspension.
+0.20Which stocks this story touches
The company faces significant headwinds due to upcoming patent expirations on major drugs and a high dividend payout ratio that risks a potential cut.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
The Motley Fool
5h ago
